Global Health Technologies Coalition (GHTC)
LightNews LightNews
banner
ghtcoalition.org
Global Health Technologies Coalition (GHTC)
@ghtcoalition.org
110 followers 170 following 370 posts
Our mission is to advance innovation to save lives. GHTC is the leading advocacy organization working to accelerate R&D for #GlobalHealth technologies. #Innovate4Health
Posts Replies Media Videos
ghtcoalition.org
What's new in #GlobalHealth R&D?
🦟Rift Valley fever #vaccine
💊#Malaria treatment alternative
💧African-made #cholera vaccine

www.ghtcoalition.org/blog/researc...
Research Roundup: Rift Valley fever vaccine, Malaria treatment alternative, African-made cholera vaccine
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
November 17, 2025 at 3:25 PM
ghtcoalition.org
There are unique challenges and multiple steps in developing tools to improve the health of people living in low-resource settings worldwide. 🔬 🧬 ➡️ 💉 💊 Learn more about that R&D journey. #GlobalHealth

www.ghtcoalition.org/pipeline-of-...
Pipeline of Promise | Global Health Technologies Coalition
Find out more about Global Health Research and Product Development Process - A Pipeline of Promise and the GOAL: Address a health need by producing a safe and effective product that is appropriate, ac...
www.ghtcoalition.org
November 14, 2025 at 8:56 PM
ghtcoalition.org
Impact Global Health estimates proposed US budget cuts could lower global health-related vaccine R&D by 41% & basic research by 42%, triggering global falls of 21% & 31%—that means fewer US-led breakthroughs, including vaccines, a key tool in our arsenal.

www.impactglobalhealth.org/insights/rep...
https://www.impactglobalhealth.org/insights/report-library/state-of-disunion-the-impact-of-us-funding-cuts-on-global-health-rd
t.co
November 14, 2025 at 8:56 PM
ghtcoalition.org
Last week, IAVI published new findings from the first-in-human Phase 1 clinical trial of its Lassa virus vaccine candidate, which show that one dose of the vaccine triggers robust and long-lasting immunity and is safe. @cepi.net

www.ghtcoalition.org/blog/researc...
https://www.ghtcoalition.org/blog/research-roundup-11-10-25
t.co
November 13, 2025 at 7:26 PM
ghtcoalition.org
Impact Global Health's new report finds that NIH grant cuts will reduce 2025 funding for HIV R&D by $18m, COVID by $15m, & malaria by $14M, while mpox, flaviviruses (Zika), uterine fibroids, and maternal iron deficiency face the biggest proportional hits.

www.impactglobalhealth.org/insights/rep...
State of disunion: The impact of US funding cuts on global health R&D
This report offers a quantified assessment of the actual and potential impact of the 2025 US funding cuts giving a system-wide, data-driven picture of the ripple effects by disease, product, research ...
www.impactglobalhealth.org
November 12, 2025 at 4:52 PM
Reposted by Global Health Technologies Coalition (GHTC)
path.org
This week, PATH is excited to participate in the @astmh.bsky.social Annual Meeting in Toronto. We'll present new insights into #malaria & other tropical diseases and share innovative, data-driven strategies addressing #GlobalHealth challenges.

See our full schedule: bit.ly/4our9tT

#TropMed25
November 11, 2025 at 2:57 PM
Reposted by Global Health Technologies Coalition (GHTC)
gardp.bsky.social
Make sure to join experts at the Antimicrobial Resistance Symposium 2025 hosted by Charité - Universitätsmedizin Berlin, focused on tackling Carbapenem-Resistant Enterobacterales (#CRE)

📍Berlin & online
🗓️ 21 Nov 2025

More details here: bit.ly/47C57zu
November 12, 2025 at 9:14 AM
Reposted by Global Health Technologies Coalition (GHTC)
gardp.bsky.social
🎥 How can we develop new antibiotics and ensure equitable access worldwide?

In this new interview by Global Health Centre, GARDP’s Jennifer Cohn and Peter Beyer discuss our not-for-profit R&D model and how cross-sector partnerships can drive antibiotic innovation.

Watch now 👇
bit.ly/47WwZNT
GARDP’s not-for-profit R&D model for antibiotics | Global Health R&D interview series
YouTube video by Global Health Centre
youtu.be
November 12, 2025 at 11:48 AM
Reposted by Global Health Technologies Coalition (GHTC)
globalhealthorg.bsky.social
Global health financing is shrinking as pandemic risks are rising. A G20 panel has called for urgent action from governments to protect against catastrophic losses. bit.ly/pandemicfinan... #pandemicpreparedness #globalhealthsecurity
November 12, 2025 at 2:30 PM
Reposted by Global Health Technologies Coalition (GHTC)
who.int
#Tuberculosis (TB) is preventable and curable.

Yet, it remains one of the world’s deadliest infectious killers, claiming 1.23 million lives in 2024.

The WHO Global Tuberculosis Report 2025 talks about the gains made so far and the challenges ahead due to severe funding cuts: bit.ly/4qT5ihk
Image of a patient in the x-ray laboratory in the background. Text reads 'Tuberculosis is the world's top infectious killer. TB caused 1.23 million deaths in 2024. Ending TB is possible. Fund it, research it, commit to it.'
November 12, 2025 at 2:51 PM
Reposted by Global Health Technologies Coalition (GHTC)
pandemiccenter.bsky.social
Global health financing is shrinking as pandemic risks are rising. The G20 High Level Independent Panel (HLIP) is calling for urgent action from governments around the globe for domestic and global financing to protect against catastrophic losses.

Read their report here ⤵️
Pandemic Financing
The G20 High Level Independent Panel sets minimum annual benchmarks for pandemic financing and urges governments to take action by or before the September
bit.ly
November 12, 2025 at 3:09 PM
ghtcoalition.org
Global health financing is shrinking as pandemic risks rise. A G20 panel, which GHTC advised, is calling for urgent action from governments to protect against catastrophic losses.

bit.ly/pandemicfina... #PandemicPreparedness #GlobalHealthSecurity
Pandemic Financing
The G20 High Level Independent Panel sets minimum annual benchmarks for pandemic financing and urges governments to take action by or before the September
bit.ly
November 12, 2025 at 2:39 PM
ghtcoalition.org
In a Phase 1 trial, an experimental vaccine against multiple H5N1 avian flu strains generated a broad immune response, demonstrating the potential of such a vaccine to play a big role in preparing for outbreaks of emerging viruses with evolving strains.

t.co/v1aEWYnKte
https://www.ghtcoalition.org/blog/research-roundup-11-10-25
t.co
November 12, 2025 at 2:23 PM
ghtcoalition.org
WHO's TB Vaccine Accelerator Council recently published a new report calling for action to ensure equitable access to future #tuberculosis vaccines currently in the pipeline.

t.co/v1aEWYncDG
https://www.ghtcoalition.org/blog/research-roundup-11-10-25
t.co
November 11, 2025 at 2:27 PM
ghtcoalition.org
Impact Global Health's new report warns that USAID’s dissolution slashed key funding, stalling HIV prevention breakthroughs and vaccine R&D for emerging diseases—just as we were reaching a turning point in HIV and global outbreaks are growing more likely.

www.impactglobalhealth.org/insights/rep...
State of disunion: The impact of US funding cuts on global health R&D
This report offers a quantified assessment of the actual and potential impact of the 2025 US funding cuts giving a system-wide, data-driven picture of the ripple effects by disease, product, research ...
www.impactglobalhealth.org
November 10, 2025 at 8:14 PM
ghtcoalition.org
What's new in #GlobalHealth R&D?
📣Call for action for future #TB vaccines
👃Intranasal H5 flu vaccine
💉Lassa vaccine trial

www.ghtcoalition.org/blog/researc...
Research Roundup: Call for action for future TB vaccines, Intranasal H5 flu vaccine, Lassa vaccine trial
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
November 10, 2025 at 3:10 PM
Reposted by Global Health Technologies Coalition (GHTC)
cepi.net
💡West Africa is one step closer to being protected against the deadly Lassa fever disease with IAVI's vaccine candidate, supported by CEPI, showing promise in the first stage of clinical testing.

Results from the Phase I trial are published in @nejm.org.
IAVI’s Lassa fever vaccine shows promise in early clinical trials | CEPI
CEPI-backed research testing the vaccine candidate's safety and immunogenicity was published in the New England Journal of Medicine.
cepi.net
November 6, 2025 at 4:18 PM
ghtcoalition.org
Last week, Cepheid announced that its Xpert MTB/XDR test for TB drug resistance has been prequalified by WHO, enabling procurement through international agencies and greater access in areas with a high TB burden.

www.ghtcoalition.org/blog/researc...
https://www.ghtcoalition.org/blog/research-roundup-11-3-25
t.co
November 6, 2025 at 6:08 PM
ghtcoalition.org
GHTC welcomes the strong R&D language in South Africa's draft #G20 health ministerial declaration and urges health ministers to strengthen the final text with concrete measures to drive tangible action.

www.ghtcoalition.org/news/ghtc-we...
GHTC welcomes strong R&D and innovation mentions in the draft G20 Polokwane declaration
GHTC welcomes the strong R&D language in South Africa's draft G20 health ministerial declaration and urges health ministers to strengthen the final text with concrete measures to drive tangible action...
www.ghtcoalition.org
November 5, 2025 at 9:41 PM
ghtcoalition.org
Researchers have developed an antivenom using antibodies from a llama and an alpaca that can neutralize venom from some of the deadliest snakes. Snakebites are a neglected public health issue that kill around 20,000 people in sub-Saharan Africa yearly.

www.ghtcoalition.org/blog/researc...
Research Roundup: Potent antibiotic, Broad-spectrum antivenom, Prequalified TB test
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
November 5, 2025 at 2:57 PM
Reposted by Global Health Technologies Coalition (GHTC)
mmv.org
Symposium: MMV & partners at #ASTMH2025

📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure

Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention

Speakers & topics 👉 bit.ly/3KVqVx7
November 3, 2025 at 6:08 PM
Reposted by Global Health Technologies Coalition (GHTC)
astmh.bsky.social
So close to the Nov 9 kick-off of #TropMed25 in Toronto! Here's our Annual Meeting blog preview: tinyurl.com/mer4yd26
November 3, 2025 at 8:43 PM
Reposted by Global Health Technologies Coalition (GHTC)
cepi.net
Broadly protective coronavirus vaccines could offer an alternative to the ‘one bug, one drug' approach.

We spoke to Dr Michael Osterholm, Director of CIDRAP, about a new CEPI-funded initiative mapping out research into all-in-one coronavirus vaccines ⬇️
cepi.net/big-one-comi...
The ‘Big One’ is coming: How can we prepare for a future coronavirus pandemic? | CEPI
Broadly protective coronavirus vaccines, built to protect us from multiple different future coronaviruses in one vaccine, could offer a vital
cepi.net
November 4, 2025 at 1:26 PM
Reposted by Global Health Technologies Coalition (GHTC)
dndi.org
🎉 We are pleased to share that the @ec.europa.eu will invest €20M to develop urgently needed dengue medicines in partnership with @afd-france.bsky.social and DNDi.
Dengue is a fast-spreading, climate-sensitive disease for which there is still no specific treatment.
🔗 bit.ly/437AJdO
November 4, 2025 at 1:44 PM
ghtcoalition.org
Researchers have identified a promising antibiotic that seems to be much more effective than existing drugs against deadly superbugs, encouraging news as the global threat of #AMR continues to grow and the pipeline of antibiotics continues to fall short.

t.co/DNOvYmfk8h
https://www.ghtcoalition.org/blog/research-roundup-11-3-25
t.co
November 4, 2025 at 2:34 PM